Skip to main content
. 2021 Jun 17;13:4767–4776. doi: 10.2147/CMAR.S308833

Figure 5.

Figure 5

Kaplan-Meier analysis of survival between patients with cholangiocarcinoma and those with other tumors. Cumulative survival rates were significantly higher in patients with cholangiocarcinoma (green line) (P = 0.001).